🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsATTAIN-2: orforglipron in T2DM — glycemic endpoints Page 4

ATTAIN-2: orforglipron in T2DM — glycemic endpoints

TrialTracker_MD Mon, May 25, 2026 at 5:34 AM 23 replies 549 viewsPage 4 of 5
SaraMom3
Member
456
2,345
Aug 2024
Ohio
May 28, 2026 at 5:43 PM#16
anna.melb_AU said:
It helps to say which part of this you are uncertain about.

Can confirm. Same sequence, different timescale. Nothing to add that would improve it.

26 24BethLabQueen, ChrisMacros, KetoKyle and 23 others
Reply Quote Save Share Report
Dr.EM_Chicago
Member
567
2,567
May 2024
Chicago, IL
May 29, 2026 at 5:27 AM#17

From the other side of the consultation, briefly. Take it one variable at a time. Almost every unanswerable question in these threads is unanswerable because three things changed in the same fortnight, and no amount of subsequent argument can untangle them after the fact.

27 0matt_MKE, Dr.ReproEndo, lucas_SP_BR and 24 others
Reply Quote Save Share Report
paige_pharma
Member
289
1,234
Sep 2024
Omaha, NE
May 29, 2026 at 5:10 PM#18
Dr.EM_Chicago said:
Almost every unanswerable question in these threads is unanswerable because three things changed in the same fortnight, and no amount of subsequent…

Adding a me-too, because a thread of one person's experience is not much use.

Last edited: May 29, 2026 at 6:10 PM
28 1adam_van, Dr.SurgeonPGH, rachel_ABQ and 25 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
claudia_zurich
Member
389
1,678
Jul 2024
Zurich, CH
May 30, 2026 at 4:54 AM#19
Dr.EM_Chicago said:
Almost every unanswerable question in these threads is unanswerable because three things changed in the same fortnight, and no amount of subsequent…

Adding the part of the answer the thread has not reached. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.

29 2alex_tucson, kevin_tulsa, Dr.PainCLE and 26 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
May 30, 2026 at 4:38 PM#20

Moderator note: the sourcing question belongs in the vendor section and has been split out.

1 24PeptideSynthNJ
Reply Quote Save Share Report

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register